+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120860
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colorectal Cancer Molecular Diagnostics Market is projected to reach USD 3.31 Billion in 2026. It is expected to continue growing at a CAGR of 6.82%, reaching USD 4.94 Billion by 2032.

Introduction to Colorectal Cancer Molecular Diagnostics

Colorectal cancer molecular diagnostics use genetic, genomic, epigenetic, and other biomarker information to support risk assessment, screening, diagnosis, treatment selection, and disease monitoring. Relevant applications include analysis of tumor tissue, blood, stool, and other specimens, with methods such as polymerase chain reaction, next-generation sequencing, immunoassays, and circulating tumor DNA testing. Clinical value depends on analytical validity, appropriate specimen handling, interpretation within care pathways, and evidence demonstrating benefit for patients.

Transformative Shifts Reshaping Diagnostic Practice

The field is shifting from pathology based primarily on morphology toward integrated workflows that combine histology with molecular characterization. Biomarker testing increasingly informs mismatch repair and microsatellite instability assessment, RAS and BRAF testing, HER2 evaluation, and broader genomic profiling in selected patients. Less invasive sampling, multiplex assays, standardized reporting, and growing attention to early detection are also changing laboratory operations. Adoption remains influenced by reimbursement, regulatory requirements, turnaround time, tissue adequacy, clinical guidelines, and equitable access to specialized testing.

How Artificial Intelligence Is Changing Molecular Diagnostics

Artificial intelligence can support colorectal cancer molecular diagnostics by identifying patterns in digital pathology, prioritizing specimens, improving image interpretation, and integrating molecular, clinical, and imaging data. Machine-learning tools may assist prediction of biomarker status or treatment response when trained on representative, well-annotated datasets. However, clinical use requires external validation, transparent performance evaluation, monitoring for bias, cybersecurity controls, and clear oversight by qualified professionals. AI should complement, rather than replace, laboratory quality systems and clinician judgment.

Regional Insights Across Global Diagnostic Systems

North America is characterized by established oncology networks, broad access to advanced laboratory testing, and active use of guideline-driven biomarker assessment, although reimbursement and access vary by jurisdiction. Europe combines strong clinical research capacity with national and regional differences in funding, procurement, and implementation; the European Union also emphasizes regulatory conformity and cross-border data governance. Asia-Pacific includes highly advanced systems alongside rapidly expanding diagnostic capacity, with Japan, Australia, South Korea, China, and India reflecting distinct policy and infrastructure environments. Latin America continues to face disparities in pathology capacity, specimen transport, and public coverage. The Middle East shows concentrated investment in specialist healthcare and precision medicine, while access differs among countries. Africa remains highly heterogeneous, with major needs in screening infrastructure, molecular laboratory capability, workforce development, and reliable supply chains.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members are addressing uneven laboratory capacity and access through regional collaboration, referral networks, and investment in workforce and diagnostic infrastructure. BRICS economies span substantial differences in healthcare resources, but share priorities around domestic capability, affordability, data systems, and integration of molecular testing into oncology pathways. The European Union is focused on coordinated standards, health-data governance, and reducing variation in access among member states. G7 countries generally combine mature clinical research ecosystems with ongoing challenges involving cost, workforce, reimbursement, and equitable implementation. GCC countries are strengthening specialist services and centralized precision-medicine capabilities, while NATO members represent diverse health systems whose common operational concerns include resilient supply chains, interoperability, and continuity of essential diagnostics.

Country-Level Developments in Colorectal Molecular Testing

Australia has strong pathology infrastructure and organized cancer-care pathways, while access can differ by geography. Brazil and Mexico are working to expand molecular testing within mixed public and private systems, with regional disparities remaining important. Canada and the United States have extensive oncology and laboratory capabilities, but coverage, reimbursement, and access vary across jurisdictions and payer settings. China is expanding precision-oncology capacity through major hospitals and regional networks. India is developing advanced diagnostic services alongside substantial affordability and access challenges. Japan and South Korea maintain sophisticated clinical and laboratory systems, while Russia’s access is shaped by domestic infrastructure, procurement, and regional variation. France, Germany, Italy, and Spain operate within established European healthcare frameworks, with differences in funding, testing pathways, and implementation. The United Kingdom combines centralized guidance with regional service variation and continuing pressure on laboratory capacity.

Actions for Leaders to Improve Clinical Value and Access

Industry leaders should align assay development with clearly defined clinical decisions, validated biomarkers, and prospective evidence rather than technology novelty alone. They should build interoperable workflows linking pathology, molecular results, electronic records, and multidisciplinary care; strengthen quality assurance across collection, transport, testing, and interpretation; and provide transparent reporting for clinicians and patients. Partnerships with health systems can address reimbursement and implementation barriers, while decentralized or referral-based models may extend access where local capacity is limited. Organizations deploying AI should establish governance for validation, bias assessment, cybersecurity, human oversight, and post-deployment monitoring. Workforce training, patient education, and responsible data stewardship should remain central to adoption.

Research Methodology for the Executive Summary

This executive summary is based on the defined scope of colorectal cancer molecular diagnostics and a structured synthesis of established clinical, technological, regulatory, and health-system considerations. The assessment organizes evidence by diagnostic application, laboratory method, implementation factor, geography, and stakeholder group. Regional, group, and country discussions are qualitative and reflect differences in healthcare infrastructure, policy, research activity, reimbursement, and access. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should be updated as clinical guidelines, regulatory decisions, validation evidence, and health-system policies evolve.

Conclusion: Building Reliable, Equitable Molecular Diagnostic Pathways

Colorectal cancer molecular diagnostics are becoming increasingly important for prevention, classification, therapy selection, and monitoring. Their impact will depend less on assay availability alone than on dependable specimen pathways, analytical and clinical validation, guideline alignment, reimbursement, skilled interpretation, and equitable integration into care. Artificial intelligence and broader genomic approaches offer meaningful opportunities, but require rigorous governance and evidence. Leaders that connect innovation with quality, interoperability, affordability, and patient-centered implementation will be best positioned to translate molecular information into better clinical decisions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Colorectal Cancer Molecular Diagnostics Market, by Technology
7.1. Introduction
7.2. Fluorescence In Situ Hybridization
7.3. Microarray
7.4. Next Generation Sequencing
7.4.1. Targeted Sequencing
7.4.2. Whole Exome Sequencing
7.4.3. Whole Genome Sequencing
7.5. Polymerase Chain Reaction
7.5.1. Digital PCR
7.5.2. Quantitative PCR
8. Colorectal Cancer Molecular Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. PCR Systems
8.2.2. Sequencers
8.3. Kits Reagents
8.4. Software Services
8.4.1. Bioinformatics Services
8.4.2. Data Analysis Software
9. Colorectal Cancer Molecular Diagnostics Market, by Application
9.1. Introduction
9.2. Companion Diagnostics
9.3. Predictive Testing
9.4. Prognostic Testing
9.5. Residual Disease Monitoring
10. Colorectal Cancer Molecular Diagnostics Market, by Biomarker
10.1. Introduction
10.2. BRAF
10.3. KRAS
10.4. Microsatellite Instability
10.5. NRAS
11. Colorectal Cancer Molecular Diagnostics Market, by Sample Type
11.1. Introduction
11.2. Blood
11.2.1. Plasma
11.2.2. Serum
11.3. Stool
11.4. Tissue
12. Colorectal Cancer Molecular Diagnostics Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Diagnostic Centers
12.4. Hospitals Clinics
12.5. Reference Laboratories
13. Colorectal Cancer Molecular Diagnostics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Colorectal Cancer Molecular Diagnostics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Colorectal Cancer Molecular Diagnostics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agilent Technologies, Inc.
17.2. Bio-Rad Laboratories, Inc.
17.3. Exact Sciences Corporation
17.4. F. Hoffmann-La Roche Ltd
17.5. Guardant Health, Inc.
17.6. Hologic, Inc.
17.7. Illumina, Inc.
17.8. Myriad Genetics, Inc.
17.9. Qiagen N.V.
17.10. Sysmex Corporation
17.11. Thermo Fisher Scientific Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Colorectal Cancer Molecular Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Colorectal Cancer Molecular Diagnostics Market, Research Design
FIGURE 3. Global Colorectal Cancer Molecular Diagnostics Market, Research Framework
FIGURE 4. Global Colorectal Cancer Molecular Diagnostics Market, Data Triangulation
FIGURE 5. Global Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2025 vs 2032 (%)
FIGURE 13. Global Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 15. Global Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Colorectal Cancer Molecular Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Colorectal Cancer Molecular Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Colorectal Cancer Molecular Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Colorectal Cancer Molecular Diagnostics Market Segmentation & Coverage
TABLE 2. Global Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Fluorescence In Situ Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Fluorescence In Situ Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Fluorescence In Situ Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Quantitative PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Quantitative PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Quantitative PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 32. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global PCR Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global PCR Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global PCR Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Kits Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Kits Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Kits Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Software Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Software Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Software Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Bioinformatics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Bioinformatics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Bioinformatics Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Predictive Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Predictive Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Predictive Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Prognostic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Prognostic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Prognostic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Residual Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Residual Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Residual Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 67. Global BRAF Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global BRAF Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global BRAF Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global KRAS Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global KRAS Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global KRAS Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Microsatellite Instability Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Microsatellite Instability Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Microsatellite Instability Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global NRAS Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global NRAS Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global NRAS Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 80. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Hospitals Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. North America Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. North America Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. North America Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 124. North America Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 125. North America Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. North America Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 127. North America Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 128. North America Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. North America Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 130. North America Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. North America Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 132. North America Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 136. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 137. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 139. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 140. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 142. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 143. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 144. Latin America Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 148. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 149. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 151. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 152. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 154. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. Europe Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 156. Europe Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 160. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 161. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 163. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 164. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 166. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 168. Middle East Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 172. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 173. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 175. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 176. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 178. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 179. Africa Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 180. Africa Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Global Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 185. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 186. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 188. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 189. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 191. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 192. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 193. ASEAN Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 197. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 198. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 200. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 201. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 203. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 204. GCC Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 205. GCC Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 209. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 210. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 212. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 213. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 215. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. European Union Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 217. European Union Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 220. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 221. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 222. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 224. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 225. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 227. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 228. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 229. BRICS Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 233. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 234. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 236. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 237. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 239. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. G7 Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 241. G7 Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 244. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 245. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 246. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 248. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 249. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 251. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. NATO Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 253. NATO Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Global Colorectal Cancer Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. United States Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 256. United States Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. United States Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 258. United States Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 259. United States Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. United States Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 261. United States Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 262. United States Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. United States Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 264. United States Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. United States Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 266. United States Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Canada Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 268. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 270. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 271. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 273. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 274. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 276. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 277. Canada Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 278. Canada Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Mexico Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 280. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 281. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 282. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 283. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 284. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 285. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 286. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 288. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 289. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 290. Mexico Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Brazil Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 292. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 294. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 295. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 297. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 298. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 299. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 300. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 301. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 302. Brazil Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 304. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 306. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 307. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 309. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Software Services, 2017-2032 (USD Million)
TABLE 310. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Biomarker, 2017-2032 (USD Million)
TABLE 312. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 313. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by Blood, 2017-2032 (USD Million)
TABLE 314. United Kingdom Colorectal Cancer Molecular Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Germany Colorectal Cancer Molecular Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 316. Germany Colorectal Cancer Molecular Dia

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Qiagen N.V.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Molecular Oncology Diagnostics Market - Global Forecast 2026-2032 - Product Image

Molecular Oncology Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2026-2032 - Product Image

Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Market Report 2026 - Product Image

Colorectal Cancer Molecular Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034 - Product Image

Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034

  • Report
  • 359 Pages
  • Global
From
Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2026-2034 - Product Image

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2026-2034

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.